Skip to main content
Fig. 2 | Immunity & Ageing

Fig. 2

From: B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice

Fig. 2

Rag1KOThy1KO ATAμκTg mice generate mature &middle age ATA B tumor. A Summary of ATAμκTg ATA B generation and old aged ATA B tumor place. ATA B IgM react with intestinal microbiota, and higher in colon, a-IgM is the control. B and C Summary of ATAμκTg with Thy-1KO or Rag1KO. Thy-1KO showed decreased B-1 ATA B cells with CD5–, rather B-2 non-ATA B cells increase. Rag1KO showed increased MZ B and B-1 ATA B, and both not generated CD5. D and E ZAP70 levels in ATA B-cell/lymphoma generation in TC–, TC+, TC–Rag1KO, and TC–Rag1KOThy-1KO mouse levels with negative FO B as set to 1.0. TC–ATAμκTg Rag1KOThy-1KOATA B mice highest ZAP70, and generated early (mature & middle) age ATA B-cell/lymphoma generation. High CD86 and high CD24 are different with old age most TC–ZAP70–CD5– ATAμκTg mice, but cyclin D2 and c-Myc are continually high as TC–ATAμκTg mice

Back to article page